SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15075521
Source:
http://linkedlifedata.com/resource/pubmed/id/15075521
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0205246
,
umls-concept:C0205263
,
umls-concept:C0442805
,
umls-concept:C0674428
pubmed:issue
5
pubmed:dateCreated
2004-4-12
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8710219
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Benzoxazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL
,
http://linkedlifedata.com/resource/pubmed/chemical/Didanosine
,
http://linkedlifedata.com/resource/pubmed/chemical/HIV Protease Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids
,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Oxazines
,
http://linkedlifedata.com/resource/pubmed/chemical/Reverse Transcriptase Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Stavudine
,
http://linkedlifedata.com/resource/pubmed/chemical/efavirenz
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0269-9370
pubmed:author
pubmed-author:ClotetBonaventuraB
,
pubmed-author:FerréRaimonR
,
pubmed-author:MasanaLluísL
,
pubmed-author:NegredoEugeniaE
,
pubmed-author:Rey-JolyCelestinoC
,
pubmed-author:RibaltaJosepJ
,
pubmed-author:SalazarJulianaJ
,
pubmed-author:SireraGuillemG
pubmed:issnType
Print
pubmed:day
26
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
819-21
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15075521-Adult
,
pubmed-meshheading:15075521-Antiretroviral Therapy, Highly Active
,
pubmed-meshheading:15075521-Benzoxazines
,
pubmed-meshheading:15075521-Cholesterol, HDL
,
pubmed-meshheading:15075521-Didanosine
,
pubmed-meshheading:15075521-Female
,
pubmed-meshheading:15075521-HIV Infections
,
pubmed-meshheading:15075521-HIV Protease Inhibitors
,
pubmed-meshheading:15075521-HIV-1
,
pubmed-meshheading:15075521-Humans
,
pubmed-meshheading:15075521-Lipids
,
pubmed-meshheading:15075521-Lipoproteins
,
pubmed-meshheading:15075521-Magnetic Resonance Spectroscopy
,
pubmed-meshheading:15075521-Male
,
pubmed-meshheading:15075521-Multivariate Analysis
,
pubmed-meshheading:15075521-Oxazines
,
pubmed-meshheading:15075521-Reverse Transcriptase Inhibitors
,
pubmed-meshheading:15075521-Stavudine
pubmed:year
2004
pubmed:articleTitle
Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study